Sinofn Health
Sinofn Health
The global demand for collagen and advanced nutraceuticals, particularly in high-growth retail channels like Chemist Warehouse, has shifted from simple supplementation to sophisticated, evidence-based formulations. As a leader in the ODM (Original Design Manufacturer) space, SINOFN bridges the gap between high-tech Chinese manufacturing efficiency and the rigorous quality standards required by international markets.
Modern procurement strategies are moving away from simple cost-cutting toward value-added partnerships. Our manufacturing processes integrate E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) into every batch:
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and deeply backed by the Chinese Academy of Sciences, we operate as a nexus for global brands seeking premium, science-backed contract manufacturing. Since 2025, our Shanghai hub has streamlined global logistics for partners.
Our founder, Mrs. GuoHong Liu, transformed clinical observation into industrial impact. Starting with life-saving PKU nutrition, she scaled the company into a multi-category powerhouse, maintaining a "Profit with Purpose" philosophy that ensures consistent quality regardless of market fluctuations.
Medical Innovation Director, Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director, Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
Consumers are demanding traceability. Our "Full-Plant Integration" model allows for blockchain batch tracking, ensuring that every unit of collagen or NMN can be traced back to its raw material source. This is the new gold standard for global procurement.
What sells in Asian markets (e.g., liquid Jiaosu drinks) requires adaptation for Western markets (e.g., ready-to-mix powders or high-potency capsules). Our R&D team specializes in Bioavailability Optimization, adjusting formulations to meet local regulatory guidelines (like TGA/FDA standards) while maintaining efficacy.
A: We operate under strict ISO 22000, HACCP, and FSSC 22000 certifications. Beyond these, our partnership with the Chinese Academy of Sciences allows us to conduct internal clinical trials and stability testing that far exceed basic industry requirements.
A: Absolutely. Our pilot-scale prototyping facilities allow brands to test new tablet, capsule, or liquid formulations in small batches before scaling up to massive production, significantly reducing time-to-market.
A: Efficiency is not just about cost; it's about speed and scale. Our 53,000 sqm facility can handle massive surges in demand without compromising the rigorous safety standards required for premium products.
